[Comparative study of the anxiolytic efficacy of lorazepam (WY 4036) and diazepam (Valium)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001007:Anxiety / Q000188:drug therapy*; D001247:Asthenia / Q000139:chemically induced; D001552:Benzazepines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003975:Diazepam / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007659:Ketones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008569:Memory Disorders / Q000139:chemically induced; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012893:Sleep Wake Disorders / Q000139:chemically induced; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D001552:Benzazepines; D007659:Ketones; D010919:Placebos; D014149:Tranquilizing Agents; D003975:Diazepam
Etude comparative contrôlée de l'effet anxiolytique du lorazepam (WY 4036) et du diazepam (Valium.